contraindications for tirzepatide (Zepbound) the Treatment of Obesity Who Should Not Take Tirzepatide:

The peptide promotes T-cell proliferation and differentiation, potentially supporting the regulatory T cell populations that are deficient in autoimmune conditions

Additionally, some patients may qualify for clinical trials, which can provide access to new medications at reduced or no cost

Summary Keywords glaucoma, GLP-1 receptor agonists, antidiabtics, ophthalmology, neuroprotection, neurodegenerative diseases Citation Mouhammad ZA, Vohra R, Horwitz A, Thein A-S, Rovelt J, Cvenkel B, Williams PA, Azuara-Blanco A and Kolko M (2022) Glucagon-Like Peptide 1 Receptor Agonists Potential Game Changers in the Treatment of Glaucoma

Attia, Y

Augsornworawat, P